Review of Preclinical Outcomes of a Topical Cationic Emulsion of Cyclosporine A for the Treatment of Ocular Surface Diseases

Daull P., Baudouin C., Liang H., Feraille L., Barabino S., Garrigue J.-S.

2021
Ocular Immunology and Inflammation

View publication

Therapeutic Area

Front of the eye (FOTE)
Technology

Drug Delivery
Categories

Preclinical development

Affiliations

Ophthalmic Innovation Center, Santen SAS, Evry, France; CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, Paris, France; Sorbonne Universités, INSERM, CNRS, Institut de la Vision, Paris, France; Iris Pharma, Les Nertières, La Gaude, France; Ocular Surface and Dry Eye Center, Ospedale L. Sacco, University of Milan, Milan, Italy

Related Publications

Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye

Daull P., Nagano T., Gros E., Feraille L., Barabino S., Garrigue J.-S.

Safety and tolerability of overdosed artificial tears by abraded rabbit corneas

Daull P., Raymond E., Feraille L., Garrigue J.-S.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022